sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
$7.10
2:31am IST
+0.14%
$7.09
$7.05
75,400
$7.20
$7.05
$10.78
$3.92
1.04
265,498
News
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Mannelly, Matthew |
President, Chief Executive Officer, Director |
-- |
| Anderson, Peter |
Chief Financial Officer |
545,759 |
| Boyko, Jean |
Senior Vice President - Science and Technology |
362,980 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
$354.05 |
| Shares Outstanding (Mil.) |
49.94 |
| Float (Mil.) |
41.90 |
| |
| Dividend Information |
| Yield % |
-99,999.99 |
| Annual Dividend ($ USD) |
0.00 |
| Payout Ratio(TTM) % |
-- |
| |
| Financial Strength |
| Quick Ratio |
2.24 |
| Current Ratio |
2.90 |
| LT Debt/Equity |
117.90 |
| Total Debt/Equity |
119.07 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
-- |
| Price/Sales(TTM) |
1.13 |
| Price/Book(TTM) |
1.17 |
| Price/Cash Flow(TTM) |
-- |
| |
|
| Per Share Data |
| Earnings(TTM) |
$-3.73 |
| Sales(TTM) |
$6.24 |
| Book Value(MRQ) |
$6.08 |
| Cash Flow(TTM) |
$-3.50 |
| Cash(MRQ) |
$0.72 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
-46.99 |
| Return on Assets(TTM) |
-20.25 |
| Return on Investment(TTM) |
-21.02 |
| |
|
| Margins |
| Gross Margin(TTM) % |
51.79 |
| Operating Margin(TTM) % |
-54.31 |
| Profit Margin(TTM) % |
-59.61 |
|
| |
|